HeimARX • ASX
add
Aroa Biosurgery Ltd
Við síðustu lokun
0,55 $
Dagbil
0,55 $ - 0,56 $
Árabil
0,44 $ - 0,87 $
Markaðsvirði
191,42 m. AUD
Meðalmagn
284,86 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
ASX
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (NZD) | mar. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 18,60 m. | 9,32% |
Rekstrarkostnaður | 18,57 m. | 20,69% |
Nettótekjur | -2,16 m. | -117,95% |
Hagnaðarhlutfall | -11,62 | -99,31% |
Hagnaður á hvern hlut | — | — |
EBITDA | -1,64 m. | -834,29% |
Virkt skatthlutfall | -1,41% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (NZD) | mar. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 30,22 m. | -34,20% |
Heildareignir | 111,06 m. | -4,69% |
Heildarskuldir | 16,12 m. | 10,18% |
Eigið fé alls | 94,94 m. | — |
Útistandandi hlutabréf | 344,21 m. | — |
Eiginfjárgengi | 1,96 | — |
Arðsemi eigna | -5,60% | — |
Ávöxtun eigin fjár | -6,07% | — |
Peningaflæði
Breyting á handbæru fé
| (NZD) | mar. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -2,16 m. | -117,95% |
Handbært fé frá rekstri | -37,00 þ. | -109,09% |
Reiðufé frá fjárfestingum | 4,11 m. | 463,36% |
Reiðufé frá fjármögnun | -239,00 þ. | -134,31% |
Breyting á handbæru fé | 3,78 m. | 409,36% |
Frjálst peningaflæði | -1,26 m. | 6,28% |
Um
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, USA and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward.
The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
Framkvæmdastjóri
Stofnsett
2008
Vefsvæði
Starfsfólk
261
